354 related articles for article (PubMed ID: 12801947)
41. Nutrient intake and risk of subtypes of esophageal and gastric cancer.
Mayne ST; Risch HA; Dubrow R; Chow WH; Gammon MD; Vaughan TL; Farrow DC; Schoenberg JB; Stanford JL; Ahsan H; West AB; Rotterdam H; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1055-62. PubMed ID: 11588131
[TBL] [Abstract][Full Text] [Related]
42. Recent incidence trends of oesophago-gastric cancer in Sweden.
Abdulkarim D; Mattsson F; Lagergren J
Acta Oncol; 2022 Dec; 61(12):1490-1498. PubMed ID: 36594265
[TBL] [Abstract][Full Text] [Related]
43. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia.
Rubenstein JH; Davis J; Marrero JA; Inadomi JM
Aliment Pharmacol Ther; 2005 Aug; 22(3):267-71. PubMed ID: 16091065
[TBL] [Abstract][Full Text] [Related]
44. Haemochromatosis and gastrointestinal cancer.
Lagergren K; Wahlin K; Mattsson F; Alderson D; Lagergren J
Int J Cancer; 2016 Oct; 139(8):1740-3. PubMed ID: 27300578
[TBL] [Abstract][Full Text] [Related]
45. Continuing rising trend in oesophageal adenocarcinoma.
Powell J; McConkey CC; Gillison EW; Spychal RT
Int J Cancer; 2002 Dec; 102(4):422-7. PubMed ID: 12402314
[TBL] [Abstract][Full Text] [Related]
46. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study.
Kokkola A; Sjöblom SM; Haapiainen R; Sipponen P; Puolakkainen P; Järvinen H
Scand J Gastroenterol; 1998 Jan; 33(1):88-92. PubMed ID: 9489914
[TBL] [Abstract][Full Text] [Related]
47. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Lagergren J; Bergström R; Lindgren A; Nyrén O
N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
[TBL] [Abstract][Full Text] [Related]
48. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.
Corley DA; Kubo A; Zhao W
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):352-8. PubMed ID: 18268119
[TBL] [Abstract][Full Text] [Related]
49. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.
Powell J; McConkey CC
Br J Cancer; 1990 Sep; 62(3):440-3. PubMed ID: 2206952
[TBL] [Abstract][Full Text] [Related]
50. Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort.
Ren JS; Kamangar F; Qiao YL; Taylor PR; Liang H; Dawsey SM; Liu B; Fan JH; Abnet CC
Gut; 2009 May; 58(5):636-42. PubMed ID: 19136509
[TBL] [Abstract][Full Text] [Related]
51. Association between body mass and adenocarcinoma of the esophagus and gastric cardia.
Lagergren J; Bergström R; Nyrén O
Ann Intern Med; 1999 Jun; 130(11):883-90. PubMed ID: 10375336
[TBL] [Abstract][Full Text] [Related]
52. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands.
Dikken JL; Lemmens VE; Wouters MW; Wijnhoven BP; Siersema PD; Nieuwenhuijzen GA; van Sandick JW; Cats A; Verheij M; Coebergh JW; van de Velde CJ
Eur J Cancer; 2012 Jul; 48(11):1624-32. PubMed ID: 22317953
[TBL] [Abstract][Full Text] [Related]
53. Incidence of cancer of oesophagus, cardia and stomach in Denmark.
Møller H
Eur J Cancer Prev; 1992 Feb; 1(2):159-64. PubMed ID: 1463978
[TBL] [Abstract][Full Text] [Related]
54. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
[TBL] [Abstract][Full Text] [Related]
55. Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia.
Nguyen AM; Luke CG; Roder D
Asian Pac J Cancer Prev; 2003; 4(3):225-31. PubMed ID: 14507243
[TBL] [Abstract][Full Text] [Related]
56. Patho-epidemiological features of esophageal and gastric cancers in an endemic region: a 20-year retrospective study.
Hajmanoochehri F; Mohammadi N; Nasirian N; Hosseinkhani M
Asian Pac J Cancer Prev; 2013; 14(6):3491-7. PubMed ID: 23886134
[TBL] [Abstract][Full Text] [Related]
57. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
58. Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort.
Sanikini H; Muller DC; Chadeau-Hyam M; Murphy N; Gunter MJ; Cross AJ
PLoS One; 2020; 15(10):e0240413. PubMed ID: 33079929
[TBL] [Abstract][Full Text] [Related]
59. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
Vaughan TL; Davis S; Kristal A; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):85-92. PubMed ID: 7742727
[TBL] [Abstract][Full Text] [Related]
60. Pernicious Anemia, Atrophic Gastritis, and the Risk of Cancer.
Kuipers EJ
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2290-2. PubMed ID: 26192144
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
